- Home
- EVH vs SLP Comparison
EVH vs SLP Comparison
Compare EVH & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVH | SLP |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | EDP Services |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 272.4M | 320.9M |
| IPO Year | 2015 | 1996 |
Fundamental Metrics
Financial Performance| Metric | EVH | SLP |
|---|---|---|
| Price | $4.00 | $13.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 6 |
| Target Price | $7.93 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 2.6M | 308.9K |
| Earning Date | 05-07-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | ★ $907,957,000.00 | $59,577,000.00 |
| Revenue This Year | $33.89 | $3.80 |
| Revenue Next Year | $15.84 | $5.90 |
| P/E Ratio | ★ N/A | $51.50 |
| Revenue Growth | N/A | ★ 10.52 |
| 52 Week Low | $2.10 | $11.09 |
| 52 Week High | $11.92 | $34.01 |
Technical Indicators
Market Signals| Indicator | EVH | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 61.40 | 41.54 |
| Support Level | $3.68 | $12.51 |
| Resistance Level | $4.32 | $15.59 |
| Average True Range (ATR) | 0.35 | 1.01 |
| MACD | 0.00 | -0.31 |
| Stochastic Oscillator | 49.30 | 0.60 |
Price Performance
Historical ComparisonAbout EVH Evolent Health Inc
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.